Iovance grants stock options covering 111,615 shares to 21 new employees
IOVA•Iovance Biotherapeutics granted inducement stock options covering 111,615 shares to 21 new, non-executive employees on October 15, 2026.
1. Option awards
The awards fall under the Amended and Restated 2021 Inducement Plan. Options vest over three years: one-third on the first anniversary of each employee’s start date, with the remainder in eight quarterly installments over the following two years, subject to continued employment through each vesting date.
